SUMITOMO CHEMICAL CO LTD (Japan) holds 4 active US FDA Type II Drug Master Files and 25 inactive, has DMF or CEP filings on record for 17 active ingredients and is linked to 3 FDA-registered manufacturing sites. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SUMITOMO CHEMICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sumitomo-chemical-co-ltd

Overview

SUMITOMO CHEMICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering BNC-1021; DISOPYRAMIDE PHOSPHATE USP; HYDRALAZINE HYDROCHLORIDE; SM-13496.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which SUMITOMO CHEMICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

SUMITOMO CHEMICAL CO LTD holds 4 active (29 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • BNC-1021Active2018-02-26
  • SM-13496Active2002-07-15
  • DISOPYRAMIDE PHOSPHATE USPActive1982-10-14
  • HYDRALAZINE HYDROCHLORIDEActive1975-03-14
  • R BACLOFENInactive2009-06-22
  • BICALUTAMIDE DRUG SUBSTANCEInactive2006-03-31
  • PBL (A STARTING MATERIAL FOR MANUFACTURING DRUG SUBSTANCES)Inactive2005-11-30
  • PBL (A STARTING MATERIAL FOR MANUFACTURING DRUG SUBSTANCES)Inactive2005-11-11
  • SNK-860Inactive2004-05-24
  • CITALOPRAM HYDROBROMIDEInactive2002-01-31
  • MIRTAZAPINEInactive2001-02-22
  • MCC-555Inactive1999-12-28
  • POTASSIUM OTASTATInactive1998-12-22
  • PAROXETINE HYDROCHLORIDE ANHYDRATEInactive1998-12-07
  • BMCB(INERMEDIATE)Inactive1997-08-29
  • SB-210272 (INTERMEDIATE)Inactive1996-08-06
  • OXAPROZINInactive1995-11-20
  • SB210272Inactive1994-05-17
  • LEVOBUNOLOL HYDROCHLORIDEInactive1992-05-11
  • DIPIVEFRIN HYDROCHLORIDEInactive1992-02-20
  • TERAZOSIN HYDROCHLORIDEInactive1991-06-06
  • GLIPIZIDEInactive1990-10-31
  • TIMOLOL MALEATEInactive1989-09-29
  • SM-8668Inactive1989-09-18
  • SC-26480 (INTERMEDIATE)Inactive1989-05-04
  • PRAZOSIN HYDROCHLORIDEInactive1987-09-25
  • CEFPIRAMIDEInactive1987-04-23
  • SUMITHRINInactive1984-11-30
  • AC - 485 MICROBEADSInactive1971-12-06

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to SUMITOMO CHEMICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

1 FDA enforcement record linked to this company.

  • warning_letter2009-08-24

    FDA Warning Letter (drug product)

For suppliers

Is this SUMITOMO CHEMICAL CO LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.